Rose Gallagher - Accelera Innovations Pres Unit
| ACNV Stock | USD 0.0001 0.00 0.00% |
Insider
Rose Gallagher is Pres Unit of Accelera Innovations
| Age | 72 |
| Phone | 866 920 0758 |
| Web | https://www.accelerainnovations.com |
Accelera Innovations Management Efficiency
The company has return on total asset (ROA) of (14.2819) % which means that it has lost $14.2819 on every $100 spent on assets. This is way below average. Accelera Innovations' management efficiency ratios could be used to measure how well Accelera Innovations manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 14 records | INSIDER Age | ||
| E Zuppas | Veeva Systems Class | 50 | |
| Jim Rivas | Doximity | N/A | |
| Pinal Patel | Veeva Systems Class | N/A | |
| Perry Gold | Doximity | N/A | |
| Shari Buck | Doximity | N/A | |
| Ato Garrett | Veeva Systems Class | N/A | |
| Mary Hedley | Veeva Systems Class | 56 | |
| Nate Gross | Doximity | N/A | |
| Nate MD | Doximity | 40 | |
| Paul Jorgensen | Doximity | 53 | |
| Priscilla Hung | Veeva Systems Class | 53 | |
| Marshall Mohr | Veeva Systems Class | 65 | |
| Tyson Murdock | HealthEquity | 53 | |
| Tina Hunt | Veeva Systems Class | 53 | |
Management Performance
| Return On Asset | -14.28 |
Accelera Innovations Leadership Team
Elected by the shareholders, the Accelera Innovations' board of directors comprises two types of representatives: Accelera Innovations inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Accelera. The board's role is to monitor Accelera Innovations' management team and ensure that shareholders' interests are well served. Accelera Innovations' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Accelera Innovations' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jimmy Lacaba, COO of Advance Lifecare | ||
| Rose Gallagher, Pres Unit | ||
| Patrick Custardo, Chief Acquisitions Officer | ||
| Geoffrey Thompson, Chairman of the Board |
Accelera Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Accelera Innovations a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -14.28 | |||
| Operating Margin | (417.96) % | |||
| Current Valuation | 1.26 M | |||
| Shares Outstanding | 81.41 M | |||
| Price To Earning | (0.22) X | |||
| Price To Sales | 162.82 X | |||
| Revenue | 2.75 K | |||
| Gross Profit | 2.75 K | |||
| EBITDA | (520.45 K) | |||
| Net Income | (1.93 M) |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Accelera Pink Sheet Analysis
When running Accelera Innovations' price analysis, check to measure Accelera Innovations' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Accelera Innovations is operating at the current time. Most of Accelera Innovations' value examination focuses on studying past and present price action to predict the probability of Accelera Innovations' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Accelera Innovations' price. Additionally, you may evaluate how the addition of Accelera Innovations to your portfolios can decrease your overall portfolio volatility.